| Date Filed | Type | Description |
| 06/16/2023 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 105,000 options to buy
@ $0.495, valued at
$52k
|
|
| 06/12/2023 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 25,000 options to buy
@ $4.83, valued at
$120.8k
|
|
| 05/18/2023 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 40,000 shares
@ $25, valued at
$1M
Exercised 40,000 options to buy
@ $1.08, valued at
$43.2k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/04/2023 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $8.52, valued at
$187.4k
|
|
| 09/20/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Bought 15,750 shares
@ $5.26, valued at
$82.8k
|
|
| 09/19/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Bought 17,147 shares
@ $5.41, valued at
$92.8k
Bought 33,481 shares
@ $5.48, valued at
$183.5k
|
|
| 09/15/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Bought 18,784 shares
@ $5.204, valued at
$97.8k
Bought 5,600 shares
@ $5.295, valued at
$29.7k
|
|
| 08/03/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 8,496 shares
@ $0.175, valued at
$1.5k
|
|
| 06/13/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 19,200 options to buy
@ $6.19, valued at
$118.8k
|
|
| 06/08/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 46,000 options to buy
@ $0.4747, valued at
$21.8k
|
|
| 01/05/2022 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
| 08/04/2021 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Sold 777 shares
@ $1.2, valued at
$932.4 |
|
| 07/30/2021 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 17,500 shares
@ $0
Granted 35,000 options to buy
@ $1.08, valued at
$37.8k
|
|
| 06/17/2021 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 40,000 options to buy
@ $4.79, valued at
$191.6k
|
|
| 06/11/2021 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 15,000 options to buy
@ $26.59, valued at
$398.9k
|
|
| 06/04/2021 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 2,250 shares
@ $0
Granted 4,500 options to buy
@ $87.13, valued at
$392.1k
|
|
| 01/13/2021 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Bought 20,408 shares
@ $24.5, valued at
$500k
|
|
| 01/06/2021 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $5.8, valued at
$127.6k
|
|
| 12/18/2020 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 10,909 shares
@ $117.82, valued at
$1.3M
Exercised 10,909 options to buy
@ $19.53, valued at
$213.1k
|
|
| 11/04/2020 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 4,478 shares
@ $99.11, valued at
$443.8k
Sold 100 shares
@ $100.48, valued at
$10k
Sold 4,728 shares
@ $99.1, valued at
$468.5k
Sold 694 shares
@ $95.97, valued at
$66.6k
Exercised 4,478 options to buy
@ $9.46, valued at
$42.4k
Exercised 5,522 options to buy
@ $9.46, valued at
$52.2k
|
|
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Orchard Therapeutics plc|
Txns:
| Granted 35,000 options to buy
@ $7.81, valued at
$273.4k
|
|
| 06/18/2020 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Converted 50,627 shares
@ $0
Bought 30,000 shares
@ $19, valued at
$570k
Converted 89,423 preferred shares
@ $0 |
|
| 06/15/2020 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 52,000 options to buy
@ $19, valued at
$988k
|
|
| 06/11/2020 |
3
| Rowland Charles A Jr (Director) has filed a Form 3 on Generation Bio Co. |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
3
| Rowland Charles A Jr (Director) has filed a Form 3 on Orchard Therapeutics plc |
| 08/01/2019 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Nabriva Therapeutics plc|
Txns:
| Granted 35,000 options
@ $0 |
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2019 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 4,875 options to buy
@ $96.77, valued at
$471.8k
Granted 1,312 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|